Document is current
Any future updates will be listed below
-
Authors
Ueki, Hiroshi https://orcid.org/0000-0002-6557-0771
Wang, I-Hsuan https://orcid.org/0000-0003-2159-7347
Kiso, Maki
Horie, Kenta https://orcid.org/0000-0003-4175-1014
Iida, Shun https://orcid.org/0000-0003-2258-9031
Mine, Sohtaro
Ujie, Michiko
Hsu, Hung-Wei
Wu, Chen-Hui Henry https://orcid.org/0009-0000-6303-920X
Imai, Masaki https://orcid.org/0000-0001-6988-1975
Suzuki, Tadaki https://orcid.org/0000-0002-3820-9542
Kamitani, Wataru
Kawakami, Eiryo https://orcid.org/0000-0001-9955-4342
Kawaoka, Yoshihiro https://orcid.org/0000-0001-5061-8296
-
Funding
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (CRIP; HHSN272201400008C)
MEXT | Japan Science and Technology Agency (JPMJMS2025)
MEXT | Japan Society for the Promotion of Science (21K14984)
Japan Agency for Medical Research and Development (JP24wm0125002, JP243fa627001, JP21fk0108552, JP20fk0108412, JP19fk0108113)
Astellas Foundation for Research on Metabolic Disorders
Naito Foundation
Sumitomo Foundation
Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care
Uehara Memorial Foundation
Okinaka Memorial Institute for Medical Research
Mochida Memorial Foundation for Medical and Pharmaceutical Research
SENSHIN Medical Research Foundation
Takeda Science Foundation
- License Information
-
More Information
Article History
Received: 1 February 2024
Accepted: 5 December 2024
First Online: 13 January 2025
Competing interests
: Y.K. has ongoing unrelated collaborations and/or sponsored research agreements with Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Shionogi & Co. Ltd, Otsuka Pharmaceutical, and KM Biologics and has received royalties from MedImmune and Integrated Biotherapeutics. The remaining authors have no competing interests to declare.
